Sonoma Pharmaceuticals (SNOA) Gross Profit (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Gross Profit of $2.2 million for Q1 2026, up 42.74% year-over-year from $1.5 million in Q1 2025, and up 32.18% quarter-over-quarter from $1.6 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Gross Profit (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Gross Profit history runs 17 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Gross Profit rose 42.74% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $7.4 million (up 35.68% YoY), while the FY2026 annual figure was $7.4 million, up 35.68% from the prior year.
- Gross Profit for Q1 2026 stood at $2.2 million, up from $1.6 million in the prior quarter.
- The five-year high for Gross Profit was $2.2 million in Q1 2026, with the low at $96000.0 in Q1 2022.
- The 5-year median for Gross Profit is $1.4 million (2024), against an average of $1.3 million.
- Peak annual rise in Gross Profit reached 800.0% in 2023, while the deepest fall reached 35.55% in 2023.
- Sonoma Pharmaceuticals' Gross Profit stood at $831000.0 in 2022, then soared by 75.69% to $1.5 million in 2023, then fell by 13.01% to $1.3 million in 2024, then grew by 29.92% to $1.6 million in 2025, then surged by 32.18% to $2.2 million in 2026.
- Business Quant data shows SNOA's Gross Profit at $2.2 million in Q1 2026, $1.6 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.19 Mn | -145,899.91 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.09 Mn |